Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly ...

Hyderabad: Mounjaro-maker Eli Lilly wants to turn India into a hub for its global supply chain, a senior executive at the U.S. drugmaker said, as part of its previously ‌committed $1 billion ...

Hyderabad: Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India’s booming obesity drug market before cheaper generic versions hit shelves in March next year.

June 26 (Reuters) - India's drug regulator on Thursday approved the launch of pre-filled injector pens of Eli Lilly's (LLY.N), opens new tab blockbuster weight-loss drug, Mounjaro, giving the company ...

Doctors field hundreds of calls about Mounjaro availability Patients now have alternatives to overseas, black market Entry gives Lilly edge over Novo Nordisk in huge market Sign up here. "Since the ...

Eli Lilly and Company (NYSE:LLY) is one of the best Fortune 500 stocks to buy according to billionaires. On June 20, Eli Lilly reported a positive reception for its blockbuster drug Mounjaro in India ...

Indianapolis-based Eli Lilly and Co. plans to invest more than $1 billion to increase contract manufacturing in India over the next several years, the company announced Monday. Lilly said the ...

Eli Lilly and Co. has entered into an agreement with India-based drugmaker Cipla to sell its blockbuster weight-loss drug, tirzepatide, under a different brand name, the company announced Thursday.

HYDERABAD, Feb 17 (Reuters) - Mounjaro-maker ⁠Eli ⁠Lilly wants to turn India ⁠into a hub for its global supply chain, a senior executive at the U.S. drugmaker said, as part of its previously committed ...